Cellnovo is an independent medical technology company specialising in diabetes, Cellnovo has developed and markets the first mobile, connected, all-in-one diabetes management system that helps make life easier for patients. Compact, tubeless, intuitive and entirely connected, CellnovoÍs insulin pump comprises a mobile touchscreen controller with an integrated blood-glucose meter. This unique device allows optimal management of insulin injections whilst ensuring extensive freedom of movement and peace of mind for patients. Thanks to the automatic transmission of data, it also allows the patientÍs condition to be continually monitored by family members and healthcare professionals in real time. Compact, tubeless, intuitive and entirely connected, CellnovoÍs insulin pump comprises a mobile touchscreen controller with an integrated blood-glucose meter. This unique device allows optimal management of insulin injections with drop-by drop precision, whilst ensuring extensive freedom of movement and peace of mind for patients. Thanks to the automatic transmission of data, it also allows the patientÍs condition to be continually monitored by family members and healthcare professionals in real time. The current version of the system has received CE Marking and is reimbursed and available in France, the United Kingdom, The Netherlands and Italy. Cellnovo has a clearly-defined expansion strategy that involves accelerating the productÍs commercialisation, initially in Europe and then in the United States and Asia, and increasing its production capacity to cope with a high level of demand.